Retrospective Study in Patients With Metastatic Renal Cancer Treated With TKI Sequence (Tyrosine Kinase Inhibitors of VEGFR) - mTOR- Axitinib Inhibitors or Anti-VEGF Antibody -Inhibiteurs mTOR - Axitinib
N/A
Describe in patients with metastatic kidney cancer treatment modalities wit...
Status
Unknown
Location
Multiple Locations
Start Date
2016-09
Trial ID
NCT03129724
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma
PHASE2
This study aims to test if patients achieving a tumor response with the com...
Status
Unknown
Location
Azienda Ospedaliera Universitaria di Cagliari- P.O. Duilio Casula Monserrato